Breast Cancer Clinical Trial
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Summary
To provide access to palbociclib to post-menopausal women with HR-positive, HER2-negative advanced breast cancer who are deemed appropriate for letrozole therapy (Canada: first-line patients only).
Full Description
This study is currently available in Canada only.
Eligibility Criteria
Inclusion Criteria:
Post-menopausal women 18 years of age or above with proven diagnosis of advanced adenocarcinoma of the breast (locoregionally recurrent or metastatic disease)
ER-positive and/or PR-positive tumor based on local laboratory results
HER2-negative tumor based on local laboratory results
Patients must be appropriate candidates for letrozole therapy (Canada: first-line patients only)
Exclusion Criteria:
Patients who have previously participated in a palbociclib trial or who have received prior treatment with any CDK inhibitor
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 50 Locations for this study
Bakersfield California, 93309, United States
Washington District of Columbia, 20007, United States
Washington District of Columbia, 20010, United States
Duluth Georgia, 30096, United States
Lawrenceville Georgia, 30046, United States
Chicago Illinois, 60657, United States
Crystal Lake Illinois, 60014, United States
Libertyville Illinois, 60048, United States
Northbrook Illinois, 60062, United States
Peoria Illinois, 61615, United States
Skokie Illinois, 60077, United States
Metairie Louisiana, 70006, United States
Baltimore Maryland, 21287, United States
Lutherville Maryland, 21093, United States
Corinth Mississippi, 38834, United States
Jackson Mississippi, 39202, United States
Jackson Mississippi, 39202, United States
Jackson Mississippi, 39216, United States
Southaven Mississippi, 38671, United States
Lake Success New York, 11042, United States
Portland Oregon, 97213, United States
Portland Oregon, 97225, United States
Beaver Pennsylvania, 15009, United States
Greensburg Pennsylvania, 15601, United States
Greenville Pennsylvania, 16125, United States
Monroeville Pennsylvania, 15146, United States
Pittsburgh Pennsylvania, 15213, United States
Pittsburgh Pennsylvania, 15215, United States
Pittsburgh Pennsylvania, 15232, United States
Pittsburgh Pennsylvania, 15232, United States
Pittsburgh Pennsylvania, 15237, United States
Pittsburgh Pennsylvania, 15237, United States
Seneca Pennsylvania, 16346, United States
State College Pennsylvania, 16803, United States
Germantown Tennessee, 38138, United States
Memphis Tennessee, 38104, United States
Memphis Tennessee, 38120, United States
Dallas Texas, 75246, United States
Houston Texas, 77024, United States
Fairfax Virginia, 22031, United States
Reston Virginia, 20190, United States
Seattle Washington, 98104, United States
Vancouver Washington, 98683, United States
Vancouver Washington, 98684, United States
Calgary Alberta, T2N 4, Canada
Calgary Alberta, T2S 3, Canada
Edmonton Alberta, T6G 1, Canada
Halifax Nova Scotia, B3H 1, Canada
London Ontario, N6A 4, Canada
Ottawa Ontario, K1H 8, Canada
Toronto Ontario, M4N 3, Canada
Toronto Ontario, M4N 3, Canada
Toronto Ontario, M4N 3, Canada
Montreal Quebec, H4A 3, Canada
Quebec , G1S 4, Canada
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.